?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
496 Unternehmen gefunden • Seite 17 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Sihuan Bioengineering Co Ltd | 23.9 | Arzneimittel (Biotechnologie) | China | 0.5 Mrd. USD | - | - | 11.83 | 10.47 | ▼ -7.38% | - | - | - | - | -10.77% | ▼ -3.77% | -8.76% | ▼ -1.60% | 21.64% | ▲ 4.69% | 7 / 9 | 0,60 | −36,0-fach | 27 / 100 | −24,6 / 100 | −3,26 | |
| Organon & Co | 23.8 | Arzneimittel (Pharmazeutisch) | USA | 3.6 Mrd. USD | 17.31 | 7.27 | 0.59 | 3.60 | ▼ -0.99% | ▼ -38.70% | 0.58% | ▼ -41.01% | - | 3.01% | ▼ -3.82% | 20.67% | ▼ -2.38% | 8.66% | ▼ -4.30% | 5 / 9 | 1,83 | 2-fach | 26 / 100 | −4,0 / 100 | −2,71 | |
![]() | BGI Genomics Co Ltd | 23.8 | Arzneimittel (Biotechnologie) | China | 2.4 Mrd. USD | - | - | 4.26 | 1.93 | ▼ -15.09% | - | - | - | - | -16.64% | ▼ -11.13% | -4.59% | ▼ -10.11% | -15.36% | ▼ -8.77% | 5 / 9 | 5,41 | −6,3-fach | 12 / 100 | −4,8 / 100 | −2,76 |
| Guangdong Taienkang Pharmaceutical Co. Ltd | 23.6 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | 329.00 | - | 13.86 | 6.32 | ▼ -0.98% | ▼ -29.19% | 0.22% | - | - | 4.24% | ▼ -3.55% | 1.95% | ▼ -5.01% | -17.95% | ▼ -6.36% | 2 / 9 | 4,83 | 14-fach | 16 / 100 | 1,8 / 100 | −2,58 | |
| Porton Fine Chemicals Ltd | 23.6 | Arzneimittel (Pharmazeutisch) | China | 1.8 Mrd. USD | - | - | 3.28 | 2.36 | ▲ 10.54% | ▼ -21.56% | 0.40% | ▼ -5.75% | - | 2.82% | ▼ -6.62% | 6.17% | ▼ -6.77% | 13.58% | ▲ 2.37% | 8 / 9 | 4,10 | 1-fach | 12 / 100 | −7,9 / 100 | −3,02 | |
![]() | Myriad Genetics Inc | 23.5 | Arzneimittel (Biotechnologie) | USA | 0.6 Mrd. USD | - | - | 0.79 | 2.09 | ▲ 8.16% | ▲ 10.34% | - | - | - | -44.38% | ▼ -7.96% | -8.22% | ▲ 4.65% | -3.10% | ▲ 1.14% | 6 / 9 | −5,85 | −47,2-fach | 82 / 100 | −52,0 / 100 | −5,19 |
| ScinoPharm Taiwan Ltd | 23.4 | Arzneimittel (Pharmazeutisch) | Taiwan | 0.5 Mrd. USD | 411.84 | 26.94 | 5.06 | 1.49 | ▲ 0.52% | ▼ -13.45% | 1.45% | ▼ -5.59% | - | 4.33% | ▼ -0.98% | 3.44% | ▼ -1.70% | 9.67% | ▲ 0.32% | 4 / 9 | 11,13 | 35-fach | 9 / 100 | −3,9 / 100 | −1,90 | |
| Mabwell (Shanghai) Bioscience Co. Ltd. A | 22.9 | Arzneimittel (Biotechnologie) | China | 1.4 Mrd. USD | - | - | 10.91 | 10.92 | ▲ 162.63% | ▲ 8.59% | - | - | - | -146.44% | ▲ 1211.53% | -144.32% | ▲ 1216.85% | -67.42% | ▲ 1166.76% | 5 / 9 | −5,91 | −17,8-fach | 9 / 100 | −15,7 / 100 | −1,53 | |
![]() | Ascentage Pharma Grp International | 22.8 | Arzneimittel (Biotechnologie) | China | 1.4 Mrd. USD | - | - | 14.30 | 16.26 | ▲ 114.04% | ▲ 12.31% | - | - | - | -216.47% | ▲ 555.35% | -211.14% | ▲ 664.73% | -214.87% | ▲ 741.84% | 3 / 9 | −5,05 | −10,9-fach | 11 / 100 | −0,9 / 100 | 1,28 |
| Staidson Beijing Biopharma | 22.8 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | - | - | 48.12 | 11.18 | ▼ -12.33% | ▼ -10.18% | - | ▲ 67.26% | 1 Jahre | -35.31% | ▼ -3.23% | -35.60% | ▲ 3.57% | -91.86% | ▼ -9.36% | 4 / 9 | 0,59 | −45,4-fach | 13 / 100 | 3,7 / 100 | −3,11 | |
![]() | Intellia Therapeutics Inc | 22.7 | Arzneimittel (Biotechnologie) | USA | 1.9 Mrd. USD | - | - | 31.37 | 2.56 | ▲ 3.13% | ▲ 26.87% | - | - | - | -609.85% | ▲ 36.48% | -651.67% | ▲ 27.33% | -524.09% | ▲ 52.93% | 4 / 9 | −5,89 | - | 6 / 100 | −7,6 / 100 | −2,88 |
![]() | Inventiva Sa | 22.6 | Arzneimittel (Biotechnologie) | Frankreich | 0.9 Mrd. USD | - | - | 575.17 | 13.29 | ▲ 64.51% | ▲ 60.82% | - | - | - | -7587.80% | ▼ -1436.58% | -2920.96% | ▼ -394.85% | -2257.86% | ▼ -278.33% | 3 / 9 | −8,73 | −11,8-fach | 1 / 100 | −96,1 / 100 | −7,05 |
| Da An Gene Co Ltd of Sun Yat-Sen University | 22.4 | Arzneimittel (Biotechnologie) | China | 1.1 Mrd. USD | - | - | 9.45 | 1.05 | ▼ -32.33% | - | - | ▼ -8.43% | - | -98.25% | ▼ -44.53% | -39.22% | ▼ -36.38% | 10.62% | ▼ -5.51% | 7 / 9 | 8,91 | −68,8-fach | 3 / 100 | −12,8 / 100 | −3,50 | |
![]() | Pacira BioSciences, Inc. | 22.3 | Arzneimittel (Pharmazeutisch) | USA | 1.4 Mrd. USD | 99.22 | 8.09 | 1.95 | 2.16 | ▲ 11.07% | ▼ -45.44% | - | - | - | 0.97% | ▼ -3.02% | 4.58% | ▼ -4.35% | 18.81% | ▲ 1.64% | 9 / 9 | 3,14 | 1-fach | 46 / 100 | −11,5 / 100 | −2,79 |
| Changchun BCHT Biotechnology Co. A | 22.2 | Arzneimittel (Pharmazeutisch) | China | 1.0 Mrd. USD | - | - | 10.68 | 1.72 | ▼ -16.31% | - | - | - | - | -45.97% | ▼ -13.05% | -61.26% | ▼ -16.26% | -29.62% | ▲ 3.51% | 5 / 9 | 4,01 | > 50-fach | 12 / 100 | −9,9 / 100 | −4,20 | |
| CARsgen Therapeutics Holdings Ltd | 22.2 | Arzneimittel (Biotechnologie) | China | 0.8 Mrd. USD | - | - | 38.78 | 4.82 | - | - | - | - | - | -77.88% | - | -82.93% | - | -193.40% | - | 5 / 9 | −16,82 | −239,1-fach | 6 / 100 | 10,7 / 100 | −0,42 | |
| Guangdong Hybribio Biotech Co Ltd | 22.2 | Arzneimittel (Biotechnologie) | China | 0.6 Mrd. USD | 57.21 | - | 5.94 | 1.04 | ▼ -13.14% | - | - | ▲ 304.53% | 5 Jahre | -19.55% | ▼ -21.40% | -20.37% | ▼ -26.10% | 37.22% | ▲ 5.64% | 5 / 9 | 12,02 | −82,5-fach | 7 / 100 | −11,2 / 100 | −3,35 | |
| Hainan Haiyao Co Ltd | 22.2 | Arzneimittel (Pharmazeutisch) | China | 0.8 Mrd. USD | - | - | 7.60 | -19.26 | ▼ -17.69% | ▼ -5.82% | - | ▲ 31.95% | - | -51.73% | ▼ -10.69% | -23.58% | ▼ -4.95% | -7.63% | ▲ 0.19% | 6 / 9 | −5,82 | −2,8-fach | 4 / 100 | −9,0 / 100 | −3,22 | |
| Sunflower Pharmaceuticals Group Co Ltd | 22.2 | Arzneimittel (Pharmazeutisch) | China | 1.0 Mrd. USD | - | - | 2.64 | 1.69 | ▼ -7.71% | - | 1.78% | ▼ -10.59% | - | -11.12% | ▼ -5.63% | -9.15% | ▼ -6.04% | 20.66% | ▼ -3.97% | 4 / 9 | 6,92 | > 50-fach | 17 / 100 | −16,1 / 100 | −4,42 | |
![]() | Protalix Biotherapeutics Inc | 22.2 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | 11.02 | 27.21 | 2.59 | 2.92 | ▼ -3.46% | ▲ 0.25% | - | - | - | -12.52% | ▲ 15.56% | -10.43% | ▲ 12.05% | -25.84% | ▲ 7.72% | 4 / 9 | −10,92 | 2-fach | 31 / 100 | 6,5 / 100 | −0,11 |
| Hengkang Medical Group Co Ltd | 21.9 | Arzneimittel (Pharmazeutisch) | China | 1.0 Mrd. USD | 97.01 | - | 2.25 | 3.32 | ▲ 1.70% | - | - | - | - | 1.01% | ▲ 2.47% | 9.03% | ▲ 4.34% | 1.20% | ▼ -0.08% | 4 / 9 | −2,43 | 2-fach | 13 / 100 | −4,0 / 100 | −2,56 | |
| ABL Bio Inc | 21.9 | Arzneimittel (Biotechnologie) | Südkorea | 1.7 Mrd. USD | - | - | 66.63 | 13.32 | ▲ 57.82% | ▼ -7.43% | - | - | - | -47.65% | ▲ 136.75% | -50.76% | ▲ 168.13% | -78.04% | ▲ 107.46% | 4 / 9 | −3,44 | −29,2-fach | 28 / 100 | 1,2 / 100 | 6,80 | |
![]() | Century Therapeutics Inc | 21.9 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 2.30 | 1.10 | ▼ -25.33% | - | - | - | - | -8.78% | ▲ 1869.42% | -13.78% | ▲ 1838.64% | -95.93% | ▲ 2377.82% | 4 / 9 | −6,31 | −497,6-fach | 43 / 100 | 42,2 / 100 | 7,02 |
| Chongqing Taiji Industry Group Co Ltd | 21.9 | Arzneimittel (Pharmazeutisch) | China | 1.0 Mrd. USD | - | 396.31 | 0.70 | 1.89 | ▼ -1.39% | ▲ 12.78% | - | - | - | 1.15% | ▲ 0.86% | 3.21% | ▲ 1.47% | 0.61% | ▼ -2.05% | 7 / 9 | −0,53 | 5-fach | 20 / 100 | −3,3 / 100 | −2,30 | |
| Tonghua Golden-Horse Pharmaceutical Industry Co Ltd | 21.6 | Arzneimittel (Pharmazeutisch) | China | 2.1 Mrd. USD | 1223.61 | - | 13.63 | 5.98 | ▲ 1.02% | - | - | - | - | 2.93% | ▲ 0.34% | 10.36% | ▲ 1.41% | 3.50% | ▼ -1.12% | 5 / 9 | 0,67 | 2-fach | 19 / 100 | −1,6 / 100 | −3,15 |